Products for Research Use Only

EGFR-IN-26

CAT: 0804-HY-142518Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-142518Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
EGFR-IN-26 is a EGFR inhibitor extracted from patent WO2019162323A1 compound I-028. EGFR-IN-26 can be used for the research of cancer[1].
CAS Number
2375470-64-5
UNSPSC
12352005
Target
VEGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/egfr-in-26.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC(C2=C(OC)C=CN=C2)=NC=C1)NC3=NC4=C(N3CC(C)(C)O)C=CC(C5CCN(CC5)C)=C4
Molecular Formula
C29H34N6O3
Molecular Weight
514.62
References & Citations
[1]BOESE D, et, al. New benzimidazole compounds and derivatives as egfr inhibitors. WO2019162323A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported